208 related articles for article (PubMed ID: 26319632)
1. Polymer nanocomposite particles of S-nitrosoglutathione: A suitable formulation for protection and sustained oral delivery.
Wu W; Gaucher C; Fries I; Hu XM; Maincent P; Sapin-Minet A
Int J Pharm; 2015 Nov; 495(1):354-361. PubMed ID: 26319632
[TBL] [Abstract][Full Text] [Related]
2. Polymer nanocomposites enhance S-nitrosoglutathione intestinal absorption and promote the formation of releasable nitric oxide stores in rat aorta.
Wu W; Perrin-Sarrado C; Ming H; Lartaud I; Maincent P; Hu XM; Sapin-Minet A; Gaucher C
Nanomedicine; 2016 Oct; 12(7):1795-1803. PubMed ID: 27184095
[TBL] [Abstract][Full Text] [Related]
3. Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin.
Zhang Y; Wei W; Lv P; Wang L; Ma G
Eur J Pharm Biopharm; 2011 Jan; 77(1):11-9. PubMed ID: 20933083
[TBL] [Abstract][Full Text] [Related]
4. Challenging development of storable particles for oral delivery of a physiological nitric oxide donor.
Zhou Y; Gaucher C; Fries I; Hobekkaya MA; Martin C; Leonard C; Deschamps F; Sapin-Minet A; Parent M
Nitric Oxide; 2020 Nov; 104-105():1-10. PubMed ID: 32771473
[TBL] [Abstract][Full Text] [Related]
5. Alginate microspheres of isoniazid for oral sustained drug delivery.
Rastogi R; Sultana Y; Aqil M; Ali A; Kumar S; Chuttani K; Mishra AK
Int J Pharm; 2007 Apr; 334(1-2):71-7. PubMed ID: 17113732
[TBL] [Abstract][Full Text] [Related]
6. Composite chitosan/alginate hydrogel for controlled release of deferoxamine: A system to potentially treat iron dysregulation diseases.
Rassu G; Salis A; Porcu EP; Giunchedi P; Roldo M; Gavini E
Carbohydr Polym; 2016 Jan; 136():1338-47. PubMed ID: 26572479
[TBL] [Abstract][Full Text] [Related]
7. Oral delivery of insulin from alginate/chitosan crosslinked by glutaraldehyde.
Tahtat D; Mahlous M; Benamer S; Khodja AN; Oussedik-Oumehdi H; Laraba-Djebari F
Int J Biol Macromol; 2013 Jul; 58():160-8. PubMed ID: 23567292
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of S-nitrosoglutathione-alginate for prolonged delivery of nitric oxide in intestines.
Shah SU; Socha M; Fries I; Gibaud S
Drug Deliv; 2016 Oct; 23(8):2927-2935. PubMed ID: 26666370
[TBL] [Abstract][Full Text] [Related]
9. Design, optimization and characterizations of chitosan fortified calcium alginate microspheres for the controlled delivery of dual drugs.
Yadav SK; Khan G; Bonde GV; Bansal M; Mishra B
Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1180-1193. PubMed ID: 28830256
[TBL] [Abstract][Full Text] [Related]
10. Alginate coated chitosan microparticles mediated oral delivery of diphtheria toxoid. Part A. Systematic optimization, development and characterization.
Shukla A; Mishra V; Bhoop BS; Katare OP
Int J Pharm; 2015 Nov; 495(1):220-233. PubMed ID: 26319633
[TBL] [Abstract][Full Text] [Related]
11. Development of coated beads for oral controlled delivery of cefaclor: In vitro evaluation.
Rasool BK; Fahmy SA
Acta Pharm; 2013 Mar; 63(1):31-44. PubMed ID: 23482311
[TBL] [Abstract][Full Text] [Related]
12. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
13. Characterization of novel composite alginate chitosan-carrageenan nanoparticles for encapsulation of BSA as a model drug delivery system.
Cheng L; Bulmer C; Margaritis A
Curr Drug Deliv; 2015; 12(3):351-7. PubMed ID: 26054536
[TBL] [Abstract][Full Text] [Related]
14. An investigation of formulation factors affecting feasibility of alginate-chitosan microparticles for oral delivery of naproxen.
Calija B; Cekić N; Savić S; Krajišnik D; Daniels R; Milić J
Arch Pharm Res; 2011 Jun; 34(6):919-29. PubMed ID: 21725813
[TBL] [Abstract][Full Text] [Related]
15. Development of modified in situ gelling oral liquid sustained release formulation of dextromethorphan.
El Maghraby GM; Elzayat EM; Alanazi FK
Drug Dev Ind Pharm; 2012 Aug; 38(8):971-8. PubMed ID: 22092113
[TBL] [Abstract][Full Text] [Related]
16. Alginate-based bipolymeric-nanobioceramic composite matrices for sustained drug release.
Hasnain MS; Nayak AK; Singh M; Tabish M; Ansari MT; Ara TJ
Int J Biol Macromol; 2016 Feb; 83():71-7. PubMed ID: 26608007
[TBL] [Abstract][Full Text] [Related]
17. Composite microparticle drug delivery systems based on chitosan, alginate and pectin with improved pH-sensitive drug release property.
Yu CY; Yin BC; Zhang W; Cheng SX; Zhang XZ; Zhuo RX
Colloids Surf B Biointerfaces; 2009 Feb; 68(2):245-9. PubMed ID: 19058952
[TBL] [Abstract][Full Text] [Related]
18. Design of antihistaminic transdermal films based on alginate-chitosan polyelectrolyte complexes: characterization and permeation studies.
Lefnaoui S; Moulai-Mostefa N; Yahoum MM; Gasmi SN
Drug Dev Ind Pharm; 2018 Mar; 44(3):432-443. PubMed ID: 29098871
[TBL] [Abstract][Full Text] [Related]
19. Alginate/chitosan nanoparticles for encapsulation and controlled release of vitamin B2.
Azevedo MA; Bourbon AI; Vicente AA; Cerqueira MA
Int J Biol Macromol; 2014 Nov; 71():141-6. PubMed ID: 24863916
[TBL] [Abstract][Full Text] [Related]
20. Multilayer sodium alginate beads with porous core containing chitosan based nanoparticles for oral delivery of anticancer drug.
Li J; Jiang C; Lang X; Kong M; Cheng X; Liu Y; Feng C; Chen X
Int J Biol Macromol; 2016 Apr; 85():1-8. PubMed ID: 26724684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
